Fewer false positives in myasthenia gravis diagnosis with improved autoantibody testing


  • There is increased diagnostic accuracy for people with myasthenia gravis (MG) when positive for both acetylcholine receptor binding (AChR-Bi) and acetylcholine receptor modulating (AChR-Mo) autoantibodies.

Why this matters ?

    With improved accuracy of MG diagnosis, there could be a reduction in unnecessary CT imaging and fewer false positives.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.